Skip to main content
Top
Published in: Nutrition & Metabolism 1/2012

Open Access 01-12-2012 | Review

Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering

Authors: Margarethe M Bosma-den Boer, Marie-Louise van Wetten, Leo Pruimboom

Published in: Nutrition & Metabolism | Issue 1/2012

Login to get access

Abstract

Serhan and colleagues introduced the term "Resoleomics" in 1996 as the process of inflammation resolution. The major discovery of Serhan's work is that onset to conclusion of an inflammation is a controlled process of the immune system (IS) and not simply the consequence of an extinguished or "exhausted" immune reaction. Resoleomics can be considered as the evolutionary mechanism of restoring homeostatic balances after injury, inflammation and infection. Under normal circumstances, Resoleomics should be able to conclude inflammatory responses. Considering the modern pandemic increase of chronic medical and psychiatric illnesses involving chronic inflammation, it has become apparent that Resoleomics is not fulfilling its potential resolving capacity. We suggest that recent drastic changes in lifestyle, including diet and psycho-emotional stress, are responsible for inflammation and for disturbances in Resoleomics. In addition, current interventions, like chronic use of anti-inflammatory medication, suppress Resoleomics. These new lifestyle factors, including the use of medication, should be considered health hazards, as they are capable of long-term or chronic activation of the central stress axes. The IS is designed to produce solutions for fast, intensive hazards, not to cope with long-term, chronic stimulation. The never-ending stress factors of recent lifestyle changes have pushed the IS and the central stress system into a constant state of activity, leading to chronically unresolved inflammation and increased vulnerability for chronic disease. Our hypothesis is that modern diet, increased psycho-emotional stress and chronic use of anti-inflammatory medication disrupt the natural process of inflammation resolution ie Resoleomics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kolb H, Mandrup-Poulsen T: The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010, 53: 10-20. 10.1007/s00125-009-1573-7.CrossRef Kolb H, Mandrup-Poulsen T: The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010, 53: 10-20. 10.1007/s00125-009-1573-7.CrossRef
2.
go back to reference Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009, 65: 732-741. 10.1016/j.biopsych.2008.11.029.CrossRef Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009, 65: 732-741. 10.1016/j.biopsych.2008.11.029.CrossRef
3.
go back to reference Serhan CN, Chiang N: Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics. Rheum Dis Clin North Am. 2004, 30: 69-95. 10.1016/S0889-857X(03)00117-0.CrossRef Serhan CN, Chiang N: Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics. Rheum Dis Clin North Am. 2004, 30: 69-95. 10.1016/S0889-857X(03)00117-0.CrossRef
4.
go back to reference Macaulay V, Richards M, Hickey E, Vega E, Cruciani F, Guida V, Scozzari R, Bonne-Tamir B, Sykes B, Torroni A: The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet. 1999, 64: 232-249. 10.1086/302204.CrossRef Macaulay V, Richards M, Hickey E, Vega E, Cruciani F, Guida V, Scozzari R, Bonne-Tamir B, Sykes B, Torroni A: The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet. 1999, 64: 232-249. 10.1086/302204.CrossRef
5.
go back to reference Smith E, Morowitz HJ: Universality in intermediary metabolism. Proc Natl Acad Sci USA. 2004, 101: 13168-13173. 10.1073/pnas.0404922101.CrossRef Smith E, Morowitz HJ: Universality in intermediary metabolism. Proc Natl Acad Sci USA. 2004, 101: 13168-13173. 10.1073/pnas.0404922101.CrossRef
6.
go back to reference Pruimboom L: Physical inactivity is a disease synonymous for a non-permissive brain disorder. Med Hypothesis. 2011, 77: 708-713. 10.1016/j.mehy.2011.07.022.CrossRef Pruimboom L: Physical inactivity is a disease synonymous for a non-permissive brain disorder. Med Hypothesis. 2011, 77: 708-713. 10.1016/j.mehy.2011.07.022.CrossRef
7.
go back to reference Cordain L, Toohey L, Smith MJ, Hickey MS: Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr. 2000, 83: 207-217.CrossRef Cordain L, Toohey L, Smith MJ, Hickey MS: Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr. 2000, 83: 207-217.CrossRef
8.
go back to reference Straub RH, Cutolo M, Buttgereit F, Pongratz G: Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010, 267: 543-560. 10.1111/j.1365-2796.2010.02218.x.CrossRef Straub RH, Cutolo M, Buttgereit F, Pongratz G: Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010, 267: 543-560. 10.1111/j.1365-2796.2010.02218.x.CrossRef
9.
go back to reference Peters A, Hitze B, Langemann D, Bosy-Westphal A, Muller MJ: Brain size, body size and longevity. Int J Obes. 2005, 34: 1349-1352.CrossRef Peters A, Hitze B, Langemann D, Bosy-Westphal A, Muller MJ: Brain size, body size and longevity. Int J Obes. 2005, 34: 1349-1352.CrossRef
10.
go back to reference Nathan C, Ding A: Nonresolving inflammation. Cell. 2010, 140: 871-882. 10.1016/j.cell.2010.02.029.CrossRef Nathan C, Ding A: Nonresolving inflammation. Cell. 2010, 140: 871-882. 10.1016/j.cell.2010.02.029.CrossRef
11.
go back to reference Serhan CN: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007, 25: 101-137. 10.1146/annurev.immunol.25.022106.141647.CrossRef Serhan CN: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007, 25: 101-137. 10.1146/annurev.immunol.25.022106.141647.CrossRef
12.
go back to reference Muskiet FAJ: The evolutionairy background, cause and consequences of chronic system low grade inflammation. Significance for clinical chemistry. Ned Tijdschr Klin Chem Labgeneesk. 2011, 36: 199-214. Muskiet FAJ: The evolutionairy background, cause and consequences of chronic system low grade inflammation. Significance for clinical chemistry. Ned Tijdschr Klin Chem Labgeneesk. 2011, 36: 199-214.
13.
go back to reference Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN: Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005, 174: 4345-4355.CrossRef Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN: Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005, 174: 4345-4355.CrossRef
14.
go back to reference Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999, 5: 698-701. 10.1038/9550.CrossRef Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999, 5: 698-701. 10.1038/9550.CrossRef
15.
go back to reference Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL: Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry. 1995, 34: 14609-14615. 10.1021/bi00044a041.CrossRef Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL: Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry. 1995, 34: 14609-14615. 10.1021/bi00044a041.CrossRef
16.
go back to reference Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M: Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med. 2009, 206: 15-23. 10.1084/jem.20081880.CrossRef Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M: Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med. 2009, 206: 15-23. 10.1084/jem.20081880.CrossRef
17.
go back to reference Willoughby DA, Moore AR, Colville-Nash PR: COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 2000, 355: 646-648. 10.1016/S0140-6736(99)12031-2.CrossRef Willoughby DA, Moore AR, Colville-Nash PR: COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 2000, 355: 646-648. 10.1016/S0140-6736(99)12031-2.CrossRef
18.
go back to reference Maddox JF, Serhan CN: Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med. 1996, 183: 137-146. 10.1084/jem.183.1.137.CrossRef Maddox JF, Serhan CN: Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med. 1996, 183: 137-146. 10.1084/jem.183.1.137.CrossRef
19.
go back to reference Maderna P, Godson C: Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 179-187. 10.1016/j.plefa.2005.05.004.CrossRef Maderna P, Godson C: Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 179-187. 10.1016/j.plefa.2005.05.004.CrossRef
20.
go back to reference Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R, Ma R, Cole SW: A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry. 2008, 64: 266-272. 10.1016/j.biopsych.2008.03.017.CrossRef Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R, Ma R, Cole SW: A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry. 2008, 64: 266-272. 10.1016/j.biopsych.2008.03.017.CrossRef
21.
go back to reference Rosas-Ballina M, Tracey KJ: The neurology of the immune system: neural reflexes regulate immunity. Neuron. 2009, 64: 28-32. 10.1016/j.neuron.2009.09.039.CrossRef Rosas-Ballina M, Tracey KJ: The neurology of the immune system: neural reflexes regulate immunity. Neuron. 2009, 64: 28-32. 10.1016/j.neuron.2009.09.039.CrossRef
22.
go back to reference Elenkov IJ: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008, 52: 40-51. 10.1016/j.neuint.2007.06.037.CrossRef Elenkov IJ: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008, 52: 40-51. 10.1016/j.neuint.2007.06.037.CrossRef
23.
go back to reference Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000, 52: 595-638. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000, 52: 595-638.
24.
go back to reference Kin NW, Sanders VM: It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006, 79: 1093-1104. 10.1189/jlb.1105625.CrossRef Kin NW, Sanders VM: It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006, 79: 1093-1104. 10.1189/jlb.1105625.CrossRef
25.
go back to reference Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL: The selfish brain: competition for energy resources. Neurosci Biobehav Rev. 2004, 28: 143-180. 10.1016/j.neubiorev.2004.03.002.CrossRef Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL: The selfish brain: competition for energy resources. Neurosci Biobehav Rev. 2004, 28: 143-180. 10.1016/j.neubiorev.2004.03.002.CrossRef
26.
go back to reference Miller GE, Cohen S, Ritchey AK: Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21: 531-541.CrossRef Miller GE, Cohen S, Ritchey AK: Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21: 531-541.CrossRef
27.
go back to reference Guarini S, Cainazzo MM, Giuliani D, Mioni C, Altavilla D, Marini H, Bigiani A, Ghiaroni V, Passaniti M, Leone S: Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res. 2004, 63: 357-365. 10.1016/j.cardiores.2004.03.029.CrossRef Guarini S, Cainazzo MM, Giuliani D, Mioni C, Altavilla D, Marini H, Bigiani A, Ghiaroni V, Passaniti M, Leone S: Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res. 2004, 63: 357-365. 10.1016/j.cardiores.2004.03.029.CrossRef
28.
go back to reference Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003, 421: 384-388. 10.1038/nature01339.CrossRef Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003, 421: 384-388. 10.1038/nature01339.CrossRef
29.
go back to reference Liezmann C, Klapp B, Peters EM: Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic persepective. Dermatol Endocrinol. 2011, 3: 37-40.CrossRef Liezmann C, Klapp B, Peters EM: Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic persepective. Dermatol Endocrinol. 2011, 3: 37-40.CrossRef
30.
go back to reference Whitaker AM, Sulzer J, Walker E, Mathis K, Molina PE: Sympathetic modulation of the host defense response to infectious challenge during recovery from hemorrhage. Neuroimmunomodulation. 2010, 17: 349-358. 10.1159/000292039.CrossRef Whitaker AM, Sulzer J, Walker E, Mathis K, Molina PE: Sympathetic modulation of the host defense response to infectious challenge during recovery from hemorrhage. Neuroimmunomodulation. 2010, 17: 349-358. 10.1159/000292039.CrossRef
31.
go back to reference Straub RH: Physiologische Grundlagen. Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen. Vandenhoe & Ruprecht. 2006 Straub RH: Physiologische Grundlagen. Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen. Vandenhoe & Ruprecht. 2006
32.
go back to reference Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056/NEJMra050541.CrossRef Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056/NEJMra050541.CrossRef
33.
go back to reference Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB: Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001, 158: 575-581. 10.1176/appi.ajp.158.4.575.CrossRef Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB: Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001, 158: 575-581. 10.1176/appi.ajp.158.4.575.CrossRef
34.
go back to reference Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A: Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry. 2008, 65: 409-415. 10.1001/archpsyc.65.4.409.CrossRef Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A: Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry. 2008, 65: 409-415. 10.1001/archpsyc.65.4.409.CrossRef
35.
go back to reference Simmons RA: Role of metabolic programming in the pathogenesis of beta-cell failure in postnatal life. Rev Endocr Metab Disord. 2007, 8: 95-104. 10.1007/s11154-007-9045-1.CrossRef Simmons RA: Role of metabolic programming in the pathogenesis of beta-cell failure in postnatal life. Rev Endocr Metab Disord. 2007, 8: 95-104. 10.1007/s11154-007-9045-1.CrossRef
36.
go back to reference Malcher-Lopes R, Buzzi M: Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoid biochemical pathways coordinates cognitive-, neuroimmune-, and energy homeostasis-related adaptations to stress. Vitam Horm. 2009, 81: 263-313.CrossRef Malcher-Lopes R, Buzzi M: Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoid biochemical pathways coordinates cognitive-, neuroimmune-, and energy homeostasis-related adaptations to stress. Vitam Horm. 2009, 81: 263-313.CrossRef
37.
go back to reference Pace TW, Hu F, Miller AH: Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007, 21: 9-19. 10.1016/j.bbi.2006.08.009.CrossRef Pace TW, Hu F, Miller AH: Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007, 21: 9-19. 10.1016/j.bbi.2006.08.009.CrossRef
38.
go back to reference Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J: Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005, 81: 341-354. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J: Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005, 81: 341-354.
39.
go back to reference Cordain L: Cereal grains: humanity's double-edged sword. World Rev Nutr Diet. 1999, 84: 19-73.CrossRef Cordain L: Cereal grains: humanity's double-edged sword. World Rev Nutr Diet. 1999, 84: 19-73.CrossRef
40.
go back to reference Patel B, Schutte R, Sporns P, Doyle J, Jewel L, Fedorak RN: Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm Bowel Dis. 2002, 8: 340-346. 10.1097/00054725-200209000-00005.CrossRef Patel B, Schutte R, Sporns P, Doyle J, Jewel L, Fedorak RN: Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm Bowel Dis. 2002, 8: 340-346. 10.1097/00054725-200209000-00005.CrossRef
41.
go back to reference Vasconcelos IM, Oliveira JT: Antinutritional properties of plant lectins. Toxicon. 2004, 44: 385-403. 10.1016/j.toxicon.2004.05.005.CrossRef Vasconcelos IM, Oliveira JT: Antinutritional properties of plant lectins. Toxicon. 2004, 44: 385-403. 10.1016/j.toxicon.2004.05.005.CrossRef
42.
go back to reference Simopoulos AP: Overview of evolutionary aspects of omega 3 fatty acids in the diet. World Rev Nutr Diet. 1998, 83: 1-11.CrossRef Simopoulos AP: Overview of evolutionary aspects of omega 3 fatty acids in the diet. World Rev Nutr Diet. 1998, 83: 1-11.CrossRef
43.
go back to reference Simopoulos AP: Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006, 60: 502-507. 10.1016/j.biopha.2006.07.080.CrossRef Simopoulos AP: Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006, 60: 502-507. 10.1016/j.biopha.2006.07.080.CrossRef
44.
go back to reference Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard JP, Desage M, Skilton MR, Vidal H, Laville M: Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr. 2008, 62: 1287-1293. 10.1038/sj.ejcn.1602857.CrossRef Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard JP, Desage M, Skilton MR, Vidal H, Laville M: Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr. 2008, 62: 1287-1293. 10.1038/sj.ejcn.1602857.CrossRef
45.
go back to reference Liou YA, King DJ, Zibrik D, Innis SM: Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr. 2007, 137: 945-952. Liou YA, King DJ, Zibrik D, Innis SM: Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr. 2007, 137: 945-952.
46.
go back to reference Wang L, Reiterer G, Toborek M, Hennig B: Changing ratios of omega-6 to omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity in endothelial cells. Chem Biol Interact. 2008, 172: 27-38. 10.1016/j.cbi.2007.11.003.CrossRef Wang L, Reiterer G, Toborek M, Hennig B: Changing ratios of omega-6 to omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity in endothelial cells. Chem Biol Interact. 2008, 172: 27-38. 10.1016/j.cbi.2007.11.003.CrossRef
47.
go back to reference Chene G, Dubourdeau M, Balard P, Escoubet-Lozach L, Orfila C, Berry A, Bernad J, Aries MF, Charveron M, Pipy B: n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim Biophys Acta. 2007, 1771: 576-589.CrossRef Chene G, Dubourdeau M, Balard P, Escoubet-Lozach L, Orfila C, Berry A, Bernad J, Aries MF, Charveron M, Pipy B: n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells. Biochim Biophys Acta. 2007, 1771: 576-589.CrossRef
48.
go back to reference Ghosh S, Novak EM, Innis SM: Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 alpha-linolenic acid ratios in normal, fat-fed pigs. Am J Physiol Heart Circ Physiol. 2007, 293: H2919-H2927. 10.1152/ajpheart.00324.2007.CrossRef Ghosh S, Novak EM, Innis SM: Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 alpha-linolenic acid ratios in normal, fat-fed pigs. Am J Physiol Heart Circ Physiol. 2007, 293: H2919-H2927. 10.1152/ajpheart.00324.2007.CrossRef
49.
go back to reference Riediger ND, Azordegan N, Harris-Janz S, Ma DW, Suh M, Moghadasian MH: 'Designer oils' low in n-6:n-3 fatty acid ratio beneficially modifies cardiovascular risks in mice. Eur J Nutr. 2009, 48: 307-314. 10.1007/s00394-009-0015-0.CrossRef Riediger ND, Azordegan N, Harris-Janz S, Ma DW, Suh M, Moghadasian MH: 'Designer oils' low in n-6:n-3 fatty acid ratio beneficially modifies cardiovascular risks in mice. Eur J Nutr. 2009, 48: 307-314. 10.1007/s00394-009-0015-0.CrossRef
50.
go back to reference Nakamura MT, Nara TY: Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr. 2004, 24: 345-376. 10.1146/annurev.nutr.24.121803.063211.CrossRef Nakamura MT, Nara TY: Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr. 2004, 24: 345-376. 10.1146/annurev.nutr.24.121803.063211.CrossRef
51.
go back to reference Calder PC: Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc. 2008, 67: 409-418. 10.1017/S0029665108008690.CrossRef Calder PC: Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc. 2008, 67: 409-418. 10.1017/S0029665108008690.CrossRef
52.
go back to reference Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab. 2006, 91: 439-446.CrossRef Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab. 2006, 91: 439-446.CrossRef
53.
go back to reference Adam O, Tesche A, Wolfram G: Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukot Essent Fatty Acids. 2008, 79: 177-181. 10.1016/j.plefa.2008.09.007.CrossRef Adam O, Tesche A, Wolfram G: Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukot Essent Fatty Acids. 2008, 79: 177-181. 10.1016/j.plefa.2008.09.007.CrossRef
54.
go back to reference McInnes IB, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007, 7: 429-442. 10.1038/nri2094.CrossRef McInnes IB, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007, 7: 429-442. 10.1038/nri2094.CrossRef
55.
go back to reference Viswanathan S, Hammock BD, Newman JW, Meerarani P, Toborek M, Hennig B: Involvement of CYP 2 C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr. 2003, 22: 502-510.CrossRef Viswanathan S, Hammock BD, Newman JW, Meerarani P, Toborek M, Hennig B: Involvement of CYP 2 C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr. 2003, 22: 502-510.CrossRef
56.
go back to reference Mangan DF, Taichman NS, Lally ET, Wahl SM: Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun. 1991, 59: 3267-3272. Mangan DF, Taichman NS, Lally ET, Wahl SM: Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun. 1991, 59: 3267-3272.
57.
go back to reference Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J: High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. Am J Clin Nutr. 2008, 87: 1188-1193. Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J: High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. Am J Clin Nutr. 2008, 87: 1188-1193.
58.
go back to reference Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002, 75: 492-498. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002, 75: 492-498.
59.
go back to reference Hu Y, Block G, Norkus EP, Morrow JD, Dietrich M, Hudes M: Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr. 2006, 84: 70-76. quiz:266-267 Hu Y, Block G, Norkus EP, Morrow JD, Dietrich M, Hudes M: Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr. 2006, 84: 70-76. quiz:266-267
60.
go back to reference Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004, 292: 1440-1446. 10.1001/jama.292.12.1440.CrossRef Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004, 292: 1440-1446. 10.1001/jama.292.12.1440.CrossRef
61.
go back to reference Du H, van der AD, van Bakel MM, van der Kallen CJ, Blaak EE, van Greevenbroek MM, Jansen EH, Nijpels G, Stehouwer CD, Dekker JM, Feskens EJ: Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr. 2008, 87: 655-661. Du H, van der AD, van Bakel MM, van der Kallen CJ, Blaak EE, van Greevenbroek MM, Jansen EH, Nijpels G, Stehouwer CD, Dekker JM, Feskens EJ: Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr. 2008, 87: 655-661.
62.
go back to reference Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS: Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004, 292: 2482-2490. 10.1001/jama.292.20.2482.CrossRef Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS: Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004, 292: 2482-2490. 10.1001/jama.292.20.2482.CrossRef
63.
go back to reference Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB: Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006, 355: 1991-2002. 10.1056/NEJMoa055317.CrossRef Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB: Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006, 355: 1991-2002. 10.1056/NEJMoa055317.CrossRef
64.
go back to reference Cordain L, Eades MR, Eades MD: Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003, 136: 95-112. 10.1016/S1095-6433(03)00011-4.CrossRef Cordain L, Eades MR, Eades MD: Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003, 136: 95-112. 10.1016/S1095-6433(03)00011-4.CrossRef
65.
go back to reference Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002, 39: 1145-1150. 10.1016/S0735-1097(02)01741-2.CrossRef Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002, 39: 1145-1150. 10.1016/S0735-1097(02)01741-2.CrossRef
66.
go back to reference Ehrmann DA: Polycystic ovary syndrome. N Engl J Med. 2005, 352: 1223-1236. 10.1056/NEJMra041536.CrossRef Ehrmann DA: Polycystic ovary syndrome. N Engl J Med. 2005, 352: 1223-1236. 10.1056/NEJMra041536.CrossRef
67.
go back to reference Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N: High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat. 2009, 114: 517-525. 10.1007/s10549-008-0019-0.CrossRef Goodwin PJ, Ennis M, Bahl M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N: High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat. 2009, 114: 517-525. 10.1007/s10549-008-0019-0.CrossRef
68.
go back to reference Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A: Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology. 2006, 147: 1830-1837.CrossRef Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A: Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology. 2006, 147: 1830-1837.CrossRef
69.
go back to reference Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007, 86: 107-115. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007, 86: 107-115.
70.
go back to reference Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinanen-Kiukaanniemi S: Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk. 2003, 10: 227-231.CrossRef Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinanen-Kiukaanniemi S: Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk. 2003, 10: 227-231.CrossRef
71.
go back to reference Barth JH, Ng LL, Wojnarowska F, Dawber RP: Acanthosis nigricans, insulin resistance and cutaneous virilism. Br J Dermatol. 1988, 118: 613-619. 10.1111/j.1365-2133.1988.tb02561.x.CrossRef Barth JH, Ng LL, Wojnarowska F, Dawber RP: Acanthosis nigricans, insulin resistance and cutaneous virilism. Br J Dermatol. 1988, 118: 613-619. 10.1111/j.1365-2133.1988.tb02561.x.CrossRef
72.
go back to reference Peters A, Langemann D: Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus. Front Neuroenergetics. 2009, 1: 2-CrossRef Peters A, Langemann D: Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus. Front Neuroenergetics. 2009, 1: 2-CrossRef
73.
go back to reference Gaujoux-Viala C, Smolen JS, Landewe R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L: Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1004-1009. 10.1136/ard.2009.127225.CrossRef Gaujoux-Viala C, Smolen JS, Landewe R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L: Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1004-1009. 10.1136/ard.2009.127225.CrossRef
74.
go back to reference Filer A, Pitzalis C, Buckley CD: Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol. 2006, 6: 393-400. 10.1016/j.coph.2006.03.007.CrossRef Filer A, Pitzalis C, Buckley CD: Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol. 2006, 6: 393-400. 10.1016/j.coph.2006.03.007.CrossRef
75.
go back to reference Das UN: Vagal nerve stimulation in prevention and management of coronary heart disease. World J Cardiol. 2010, 3: 105-110.CrossRef Das UN: Vagal nerve stimulation in prevention and management of coronary heart disease. World J Cardiol. 2010, 3: 105-110.CrossRef
76.
go back to reference Desneves KJ, Todorovic BE, Cassar A, Crowe TC: Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clin Nutr (Edinburgh, Scotland). 2005, 24: 979-987. 10.1016/j.clnu.2005.06.011.CrossRef Desneves KJ, Todorovic BE, Cassar A, Crowe TC: Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clin Nutr (Edinburgh, Scotland). 2005, 24: 979-987. 10.1016/j.clnu.2005.06.011.CrossRef
77.
go back to reference Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN: Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med. 2002, 8: 1296-1302. 10.1038/nm786.CrossRef Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN: Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med. 2002, 8: 1296-1302. 10.1038/nm786.CrossRef
78.
go back to reference Roth GJ, Stanford N, Majerus PW: Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA. 1975, 72: 3073-3076. 10.1073/pnas.72.8.3073.CrossRef Roth GJ, Stanford N, Majerus PW: Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA. 1975, 72: 3073-3076. 10.1073/pnas.72.8.3073.CrossRef
79.
go back to reference Serhan CN: Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 141-162. 10.1016/j.plefa.2005.05.002.CrossRef Serhan CN: Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 141-162. 10.1016/j.plefa.2005.05.002.CrossRef
80.
go back to reference Gilroy DW: The role of aspirin-triggered lipoxins in the mechanism of action of aspirin. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 203-210. 10.1016/j.plefa.2005.05.007.CrossRef Gilroy DW: The role of aspirin-triggered lipoxins in the mechanism of action of aspirin. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 203-210. 10.1016/j.plefa.2005.05.007.CrossRef
81.
go back to reference Claria J, Serhan CN: Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA. 1995, 92: 9475-9479. 10.1073/pnas.92.21.9475.CrossRef Claria J, Serhan CN: Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA. 1995, 92: 9475-9479. 10.1073/pnas.92.21.9475.CrossRef
82.
go back to reference Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW: 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med. 2004, 200: 69-78. 10.1084/jem.20040566.CrossRef Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW: 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med. 2004, 200: 69-78. 10.1084/jem.20040566.CrossRef
83.
go back to reference Serhan CN, Takano T, Chiang N, Gronert K, Clish CB: Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis: Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. Am J Respir Crit Care Med. 2000, 161: S95-S101.CrossRef Serhan CN, Takano T, Chiang N, Gronert K, Clish CB: Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis: Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. Am J Respir Crit Care Med. 2000, 161: S95-S101.CrossRef
84.
go back to reference Bertolini A, Ottani A, Sandrini M: Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res. 2001, 44: 437-450. 10.1006/phrs.2001.0872.CrossRef Bertolini A, Ottani A, Sandrini M: Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res. 2001, 44: 437-450. 10.1006/phrs.2001.0872.CrossRef
85.
go back to reference Warner TD, Mitchell JA: Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004, 18: 790-804. 10.1096/fj.03-0645rev.CrossRef Warner TD, Mitchell JA: Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004, 18: 790-804. 10.1096/fj.03-0645rev.CrossRef
86.
go back to reference Wahl C, Liptay S, Adler G, Schmid RM: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998, 101: 1163-1174. 10.1172/JCI992.CrossRef Wahl C, Liptay S, Adler G, Schmid RM: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998, 101: 1163-1174. 10.1172/JCI992.CrossRef
87.
go back to reference Barnes PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998, 94: 557-572.CrossRef Barnes PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998, 94: 557-572.CrossRef
88.
go back to reference Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP: Mechanisms of action of methotrexate. Immunopharmacology. 2000, 47: 247-257. 10.1016/S0162-3109(00)00189-2.CrossRef Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP: Mechanisms of action of methotrexate. Immunopharmacology. 2000, 47: 247-257. 10.1016/S0162-3109(00)00189-2.CrossRef
89.
go back to reference Baggott JE, Morgan SL, Ha TS, Alarcon GS, Koopman WJ, Krumdieck CL: Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol. 1993, 11 (Suppl 8): S101-S105. Baggott JE, Morgan SL, Ha TS, Alarcon GS, Koopman WJ, Krumdieck CL: Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol. 1993, 11 (Suppl 8): S101-S105.
90.
go back to reference Chan ES, Cronstein BN: Methotrexate-how does it really work?. Nat Rev Rheumatol. 2010, 6: 175-178. 10.1038/nrrheum.2010.5.CrossRef Chan ES, Cronstein BN: Methotrexate-how does it really work?. Nat Rev Rheumatol. 2010, 6: 175-178. 10.1038/nrrheum.2010.5.CrossRef
91.
go back to reference Cronstein BN: Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum. 1996, 39: 1951-1960. 10.1002/art.1780391203.CrossRef Cronstein BN: Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum. 1996, 39: 1951-1960. 10.1002/art.1780391203.CrossRef
92.
go back to reference Cronstein BN, Naime D, Ostad E: The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993, 92: 2675-2682. 10.1172/JCI116884.CrossRef Cronstein BN, Naime D, Ostad E: The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993, 92: 2675-2682. 10.1172/JCI116884.CrossRef
93.
go back to reference Herman S, Zurgil N, Deutsch M: Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res. 2005, 54: 273-280. 10.1007/s00011-005-1355-8.CrossRef Herman S, Zurgil N, Deutsch M: Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res. 2005, 54: 273-280. 10.1007/s00011-005-1355-8.CrossRef
94.
go back to reference Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M: he immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations. Immunol Invest. 2004, 33: 351-362. 10.1081/IMM-120039865.CrossRef Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M: he immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations. Immunol Invest. 2004, 33: 351-362. 10.1081/IMM-120039865.CrossRef
95.
go back to reference Kim YJ, Song M, Ryu JC: Mechanisms underlying methotrexate-induced pulmonary toxicity. Expert Opin Drug Saf. 2009, 8: 451-458. 10.1517/14740330903066734.CrossRef Kim YJ, Song M, Ryu JC: Mechanisms underlying methotrexate-induced pulmonary toxicity. Expert Opin Drug Saf. 2009, 8: 451-458. 10.1517/14740330903066734.CrossRef
96.
go back to reference Nesher G, Moore TL: The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum. 1990, 33: 954-959. 10.1002/art.1780330706.CrossRef Nesher G, Moore TL: The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum. 1990, 33: 954-959. 10.1002/art.1780330706.CrossRef
97.
go back to reference Olsen NJ, Callahan LF, Pincus T: Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1987, 30: 481-488. 10.1002/art.1780300501.CrossRef Olsen NJ, Callahan LF, Pincus T: Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1987, 30: 481-488. 10.1002/art.1780300501.CrossRef
98.
go back to reference Olsen NJ, Murray LM: Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum. 1989, 32: 378-385. 10.1002/anr.1780320404.CrossRef Olsen NJ, Murray LM: Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum. 1989, 32: 378-385. 10.1002/anr.1780320404.CrossRef
99.
go back to reference Phillips DC, Woollard KJ, Griffiths HR: The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol. 2003, 138: 501-511. 10.1038/sj.bjp.0705054.CrossRef Phillips DC, Woollard KJ, Griffiths HR: The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol. 2003, 138: 501-511. 10.1038/sj.bjp.0705054.CrossRef
100.
go back to reference Sperling RI, Coblyn JS, Larkin JK, Benincaso AI, Austen KF, Weinblatt ME: Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. Arthritis Rheum. 1990, 33: 1149-1155.CrossRef Sperling RI, Coblyn JS, Larkin JK, Benincaso AI, Austen KF, Weinblatt ME: Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. Arthritis Rheum. 1990, 33: 1149-1155.CrossRef
101.
go back to reference Thomas R, Carroll GJ: Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1993, 36: 1244-1252. 10.1002/art.1780360909.CrossRef Thomas R, Carroll GJ: Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1993, 36: 1244-1252. 10.1002/art.1780360909.CrossRef
102.
go back to reference van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB: Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum. 1998, 27: 277-292. 10.1016/S0049-0172(98)80049-8.CrossRef van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB: Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum. 1998, 27: 277-292. 10.1016/S0049-0172(98)80049-8.CrossRef
103.
go back to reference McInnes IB, Gracie JA: Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis. Curr Pain Headache Rep. 2005, 9: 405-411. 10.1007/s11916-005-0020-9.CrossRef McInnes IB, Gracie JA: Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis. Curr Pain Headache Rep. 2005, 9: 405-411. 10.1007/s11916-005-0020-9.CrossRef
104.
go back to reference Scott DL, Kingsley GH: Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006, 355: 704-712. 10.1056/NEJMct055183.CrossRef Scott DL, Kingsley GH: Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006, 355: 704-712. 10.1056/NEJMct055183.CrossRef
105.
go back to reference Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M: Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005, 7: R784-R795. 10.1186/ar1733.CrossRef Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M: Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005, 7: R784-R795. 10.1186/ar1733.CrossRef
106.
go back to reference Planaguma A, Titos E, Lopez-Parra M, Gaya J, Pueyo G, Arroyo V, Claria J: Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 2002, 16: 1937-1939. Planaguma A, Titos E, Lopez-Parra M, Gaya J, Pueyo G, Arroyo V, Claria J: Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 2002, 16: 1937-1939.
107.
go back to reference Bannenberg GL: Therapeutic applicability of anti-inflammatory and proresolving polyunsaturated fatty acid-derived lipid mediators. Sci World J. 2010, 10: 676-712.CrossRef Bannenberg GL: Therapeutic applicability of anti-inflammatory and proresolving polyunsaturated fatty acid-derived lipid mediators. Sci World J. 2010, 10: 676-712.CrossRef
108.
go back to reference Yacoubian S, Serhan CN: New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007, 3: 570-579. 10.1038/ncprheum0616. quiz 571 p following 589CrossRef Yacoubian S, Serhan CN: New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007, 3: 570-579. 10.1038/ncprheum0616. quiz 571 p following 589CrossRef
109.
go back to reference Basselin M, Ramadan E, Chen M, Rapoport SI: Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochem Res. 2011, 36: 139-145. 10.1007/s11064-010-0282-4.CrossRef Basselin M, Ramadan E, Chen M, Rapoport SI: Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochem Res. 2011, 36: 139-145. 10.1007/s11064-010-0282-4.CrossRef
110.
go back to reference Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995, 270: 283-286. 10.1126/science.270.5234.283.CrossRef Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995, 270: 283-286. 10.1126/science.270.5234.283.CrossRef
111.
go back to reference MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF: Inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology. 1989, 96: 442-448. MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF: Inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology. 1989, 96: 442-448.
112.
go back to reference Tanabe T, Tohnai N: Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat. 2002, 68-69: 95-114.CrossRef Tanabe T, Tohnai N: Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat. 2002, 68-69: 95-114.CrossRef
113.
go back to reference Miller AH: Depression and immunity: a role for T cells?. Brain Behav Immun. 2010, 24: 1-8. 10.1016/j.bbi.2009.09.009.CrossRef Miller AH: Depression and immunity: a role for T cells?. Brain Behav Immun. 2010, 24: 1-8. 10.1016/j.bbi.2009.09.009.CrossRef
114.
go back to reference Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971, 231: 232-235.CrossRef Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971, 231: 232-235.CrossRef
115.
go back to reference Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL: Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J. 2003, 17: 1171-1173. Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL: Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J. 2003, 17: 1171-1173.
116.
go back to reference Tabor CW, Tabor H: Polyamines. Annu Rev Biochem. 1984, 53: 749-790. 10.1146/annurev.bi.53.070184.003533.CrossRef Tabor CW, Tabor H: Polyamines. Annu Rev Biochem. 1984, 53: 749-790. 10.1146/annurev.bi.53.070184.003533.CrossRef
117.
go back to reference Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867. 10.1038/nature05485.CrossRef Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867. 10.1038/nature05485.CrossRef
118.
go back to reference Fall CHD: Developmental origins of cardiovascular disease, type 2 diabetes and obesity in humans. Early Life Orig Health Dis. 2006, 2: 8-28.CrossRef Fall CHD: Developmental origins of cardiovascular disease, type 2 diabetes and obesity in humans. Early Life Orig Health Dis. 2006, 2: 8-28.CrossRef
119.
go back to reference Egger G, Dixon J: Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev. 2010, 11: 137-149. 10.1111/j.1467-789X.2009.00644.x.CrossRef Egger G, Dixon J: Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev. 2010, 11: 137-149. 10.1111/j.1467-789X.2009.00644.x.CrossRef
120.
go back to reference Eaton SB, Cordain L, Sparling PB: Evolution, body composition, insulin receptor competition, and insulin resistance. Prev Med. 2009, 49: 283-285. 10.1016/j.ypmed.2009.08.002.CrossRef Eaton SB, Cordain L, Sparling PB: Evolution, body composition, insulin receptor competition, and insulin resistance. Prev Med. 2009, 49: 283-285. 10.1016/j.ypmed.2009.08.002.CrossRef
121.
go back to reference Frassetto LA, Schloetter M, Mietus-Synder M, Morris RC: Sebastian A: Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur J Clin Nutr. 2009, 63: 947-955. 10.1038/ejcn.2009.4.CrossRef Frassetto LA, Schloetter M, Mietus-Synder M, Morris RC: Sebastian A: Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur J Clin Nutr. 2009, 63: 947-955. 10.1038/ejcn.2009.4.CrossRef
122.
go back to reference O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984, 33: 596-603. 10.2337/diabetes.33.6.596.CrossRef O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984, 33: 596-603. 10.2337/diabetes.33.6.596.CrossRef
123.
go back to reference McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009, 12: 342-348. 10.1038/nn.2270.CrossRef McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009, 12: 342-348. 10.1038/nn.2270.CrossRef
124.
go back to reference Cutolo M, Foppiani L, Minuto F: Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest. 2002, 25: 19-23.CrossRef Cutolo M, Foppiani L, Minuto F: Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest. 2002, 25: 19-23.CrossRef
125.
go back to reference Strohle A, Scheel M, Modell S, Holsboer F: Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. J Psychiatr Res. 2008, 42: 1185-1188. 10.1016/j.jpsychires.2008.01.015.CrossRef Strohle A, Scheel M, Modell S, Holsboer F: Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. J Psychiatr Res. 2008, 42: 1185-1188. 10.1016/j.jpsychires.2008.01.015.CrossRef
126.
go back to reference Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ: Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology. 2007, 55: 112-120. 10.1159/000104468.CrossRef Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ: Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology. 2007, 55: 112-120. 10.1159/000104468.CrossRef
127.
go back to reference Cobb JM, Steptoe A: Psychosocial stress and susceptibility to upper respiratory tract illness in an adult population sample. Psychosom Med. 1996, 58: 404-412.CrossRef Cobb JM, Steptoe A: Psychosocial stress and susceptibility to upper respiratory tract illness in an adult population sample. Psychosom Med. 1996, 58: 404-412.CrossRef
128.
go back to reference Segerstrom SC: Social networks and immunosuppression during stress: relationship conflict or energy conservation?. Brain Behav Immun. 2008, 22: 279-284. 10.1016/j.bbi.2007.10.011.CrossRef Segerstrom SC: Social networks and immunosuppression during stress: relationship conflict or energy conservation?. Brain Behav Immun. 2008, 22: 279-284. 10.1016/j.bbi.2007.10.011.CrossRef
Metadata
Title
Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
Authors
Margarethe M Bosma-den Boer
Marie-Louise van Wetten
Leo Pruimboom
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2012
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-9-32

Other articles of this Issue 1/2012

Nutrition & Metabolism 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.